XML 20 R8.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Operating Activities      
Net earnings $ 150,400,000 $ 6,600,000 $ 49,100,000
Adjustments to reconcile net earnings to cash from operating activities:      
Depreciation and amortization 62,500,000 60,600,000 54,400,000
Stock-based compensation 32,100,000 17,300,000 25,200,000
Non-cash interest expense and amortization of debt issuance costs 8,000,000.0 8,900,000 8,100,000
Total impairment charges 4,000,000 7,600,000 0
Impaired Assets to be Disposed of by Method Other than Sale, Amount of Impairment Loss 0 1,700,000 0
Gain (Loss) on Disposition of Property Plant Equipment 0 300,000 200,000
Deferred income taxes (61,200,000) (2,600,000) (700,000)
Other, net 0 5,000,000.0 1,300,000
Changes in assets and liabilities (excluding effects of foreign exchange):      
Receivables, net (12,300,000) 29,000,000.0 (17,800,000)
Inventories, net (20,700,000) 16,700,000 (300,000)
Prepaid and other current assets (2,900,000) (100,000) 2,700,000
Accounts payable 17,200,000 (17,500,000) 12,100,000
Accrued compensation and employee benefits 11,900,000 (2,100,000) (8,100,000)
Other accrued expenses 1,800,000 2,600,000 (600,000)
Accrued taxes (1,100,000) (5,800,000) 2,700,000
Other non-current assets and non-current liabilities (7,600,000) (100,000) (4,400,000)
Net cash provided by operating activities 182,100,000 128,100,000 123,900,000
Investing Activities      
Payments for (Proceeds from) Investments (3,500,000) (3,500,000) 0
Proceeds from the sale of property, plant, and equipment 600,000 300,000 0
Proceeds from Sale of Short-term Investments 400,000 0 0
Additions to property, plant, and equipment (48,600,000) (31,900,000) (41,200,000)
Acquisitions of business (net of cash acquired) (78,500,000) 0 (69,300,000)
Net cash used in investing activities (129,600,000) (35,100,000) (110,500,000)
Financing Activities      
Payments under revolving credit facility 0 (100,000,000.0) (19,000,000.0)
Borrowings under revolving credit facility 70,000,000.0 100,000,000.0 10,000,000.0
Payments for Repurchase of Common Stock (44,500,000) (16,200,000) 0
Payments of debt issuance costs 0 (1,400,000) 0
Payment for Contingent Consideration Liability, Financing Activities 0 0 (1,200,000)
Payments of finance lease obligations (2,300,000) (2,000,000.0) (1,700,000)
Tax on restricted and performance stock unit vesting (7,700,000) (6,100,000) (6,400,000)
Proceeds from exercise of stock-based awards 25,600,000 1,800,000 9,800,000
Net cash used in financing activities (131,400,000) (23,900,000) (8,500,000)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 0 300,000 0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total (78,900,000) 69,400,000 4,900,000
Cash and Cash Equivalents, at Carrying Value, Including Discontinued Operations 68,900,000 147,800,000 78,400,000
Supplemental information - cash paid during the year for:      
Income taxes 16,100,000 16,800,000 12,100,000
Interest 7,400,000 8,100,000 7,500,000
Convertible Notes Due Twenty Twenty One [Member] | Convertible Debt      
Financing Activities      
Proceeds from issuance of warrants 39,100,000    
Purchase of convertible note hedges (44,500,000)    
Supplemental information - cash paid during the year for:      
Debt instrument, face amount 172,500,000 0 0
Debt instrument, face amount $ 172,500,000 $ 0 $ 0